Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EPSN vs GFR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EPSN Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 5–5 Matrix Metrics)

EPSN Overall Winner 6-Pillar Tally: EPSN 3 – 2 GFR (1 Tie) Matrix Metrics: EPSN 5 – 5 GFR

As of Nov 20, 2026, Epsilon Energy Ltd. (EPSN) is the stronger overall head-to-head candidate over Greenfire Resources Ltd. (GFR) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). EPSN carries a Unified Composite Score of 41.6/100 (SELL) at $4.80 (15.6x Forward P/E, 24.6% operating margin), whereas GFR carries 31.3/100 (SELL) at $7.64 (9.5x Forward P/E, -1.1% operating margin).

  • Growth vs. Quality Trade-Off: EPSN earns the overall head-to-head edge with a stronger Unified Composite Score (41.6/100 SELL vs. GFR 31.3/100 SELL) and -0.31β · 43% Vol risk profile, whereas GFR leads top-line expansion (+97.7% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although EPSN compares more favorably head-to-head, both EPSN (41.6/100 SELL) and GFR (31.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: EPSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.6); meanwhile GFR trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 62.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EPSN vs GFR
EPSN NASDAQ Head-to-Head Winner
Epsilon Energy Ltd.
Crude Petroleum & Natural Gas
$4.80
-3.03% 1D
Market Cap $149.9M
TTM Revenue $68M
Forward P/E 15.6x
Beta / 30D Vol -0.31β · 43% Vol
Unified Composite Score
41.6 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 26
RSI-14: 25.6 · SMA20: $5.59 · SMA50: $5.84
GFR NYSE
Greenfire Resources Ltd.
Crude Petroleum & Natural Gas
$7.64
-0.39% 1D
Market Cap $1.8B
TTM Revenue $715M
Forward P/E 9.5x
Beta / 30D Vol 0.14β · 140% Vol
Unified Composite Score
31.3 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.5% over 20 days), RSI 63
RSI-14: 62.8 · SMA20: $7.01 · SMA50: $6.61

6-Pillar Scorecard Institutional Category Breakdown (EPSN 3 – 2 GFR)

Columns: Metric · EPSN · GFR
1. Valuation Multiples GFR
Forward P/E 15.6x 9.5x
Trailing P/E 15.6x 8.4x
PEG Ratio N/M N/M
EV / Revenue 2.2x 2.6x
2. Growth & Scale GFR
Revenue Growth (YoY) +57.1% +97.7%
Earnings Growth (YoY) +228.6% -38.2%
TTM Revenue (USD) $68M $715M
Market Cap $149.9M $1.8B
3. Profitability & Quality EPSN
Gross Margin 65.8% 34.6%
Operating Margin 24.6% -1.1%
Net Profit Margin -5.2% -6.9%
Return on Equity (ROE) -3.0% -3.5%
4. Balance Sheet & Cash Flow EPSN
Cash Generation (TTM) $29M EBITDA $101M EBITDA
Cash Flow Margin 43.2% EBITDA Mgn 14.2% EBITDA Mgn
Net Cash / Leverage $4.29 Book/Sh · -3.0% ROE $5.63 Book/Sh · -3.5% ROE
Dividend Yield 4.77% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 51.0% (13th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat EPSN
OpEx & R&D Intensity 41.2% of Rev ($28M) 35.7% of Rev ($255M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Oil & Gas E&P Operator Oil & Gas E&P Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EPSN (5) vs GFR (5)
Institutional Metric EPSN GFR Criterion Row Edge
Market Capitalization
Scale
$149.9M $1.8B Larger Scale GFR
Trailing P/E Ratio
Valuation
15.6x 8.4x Lower Multiple GFR
Forward P/E Ratio
Valuation
15.6x 9.5x Lower Multiple GFR
Revenue Growth (YoY)
Growth
+57.1% +97.7% Higher Growth GFR
Operating Margin (TTM)
Profitability
24.6% -1.1% Higher Margin EPSN
Net Profit Margin
Profitability
-5.2% -6.9% Higher Margin EPSN
Return on Equity (ROE)
Capital Efficiency
-3.0% -3.5% Higher ROE EPSN
52-Week Range Position
Momentum
24% ($4–$7) 95% ($4–$8) Stronger Trend GFR
Beta / 30D Volatility
Risk Regime
-0.31β · 43% Vol 0.14β · 140% Vol Lower Realized Risk EPSN
Unified Institutional Score
Composite Signal
41.6 / 100 (SELL) 31.3 / 100 (SELL) Higher Composite EPSN
Trailing 12M Revenue (USD)
Operating Scale
$68M $715M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
65.8% 34.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.2x EV/Rev N/M PEG · 2.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$29M EBITDA ($4.29 Book/Sh · -3.0% ROE) $101M EBITDA ($5.63 Book/Sh · -3.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GFR +36.62 pp
EPSN: -22.08% · GFR: +14.54%
3M Horizon GFR +34.57 pp
EPSN: -14.44% · GFR: +20.13%
6M Horizon GFR +49.37 pp
EPSN: -22.46% · GFR: +26.91%
1Y Horizon GFR +49.55 pp
EPSN: +0.84% · GFR: +50.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EPSN vs GFR. Trailing 12-month operating profitability (EPSN 24.6% vs GFR -1.1%) and valuation multiples (EPSN 15.6x vs GFR 9.5x Forward P/E) are benchmarked directly in Pillar 4 below.

EPSN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$68M
Gross Margin65.8%
Op. Margin24.6%
ROE / Fwd P/E-3.0% · 15.6x
GFR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$715M
Gross Margin34.6%
Op. Margin-1.1%
ROE / Fwd P/E-3.5% · 9.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EPSN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 51.0%
IV Percentile 13th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EPSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GFR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GFR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EPSN Moat Profile Scale & Operating Efficiency Moat
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $149.9M market capitalization and 24.6% operating margin.
OpEx & R&D Reinvestment 41.2% of Rev ($28M)
90D Engineering Disclosures 0 Published
GFR Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.8B market capitalization and -1.1% operating margin.
OpEx & R&D Reinvestment 35.7% of Rev ($255M)
90D Engineering Disclosures 0 Published

Investor FAQ EPSN vs GFR Key Questions & Quantitative Answers

As of Nov 20, 2026, Epsilon Energy Ltd. (EPSN) is the stronger overall head-to-head candidate over Greenfire Resources Ltd. (GFR) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). EPSN carries a Unified Composite Score of 41.6/100 (SELL) at $4.80 (15.6x Forward P/E, 24.6% operating margin), whereas GFR carries 31.3/100 (SELL) at $7.64 (9.5x Forward P/E, -1.1% operating margin). Growth vs. Quality Trade-Off: EPSN earns the overall head-to-head edge with a stronger Unified Composite Score (41.6/100 SELL vs. GFR 31.3/100 SELL) and -0.31β · 43% Vol risk profile, whereas GFR leads top-line expansion (+97.7% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although EPSN compares more favorably head-to-head, both EPSN (41.6/100 SELL) and GFR (31.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: EPSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.6); meanwhile GFR trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 62.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GFR leads the Growth & Scale pillar: EPSN posts +57.1% YoY revenue growth and +228.6% YoY earnings growth on $68M TTM revenue (65.8% gross margin, 24.6% operating margin), compared with GFR at +97.7% YoY revenue growth and -38.2% YoY earnings growth on $715M TTM revenue (34.6% gross margin, -1.1% operating margin). On trailing 12-month operating scale, EPSN generates $68M in USD-normalized revenue versus $715M for GFR. In operating R&D and SG&A reinvestment, EPSN deploys 41.2% of Rev ($28M) (0 90-day corporate R&D disclosures) versus 35.7% of Rev ($255M) (0 disclosures) for GFR.

GFR screens cheaper on headline valuation multiples. EPSN trades at 15.6x Forward P/E, 15.6x Trailing P/E, N/M PEG, and 2.2x EV/Revenue (43.2% EBITDA margin), whereas GFR trades at 9.5x Forward P/E, 8.4x Trailing P/E, N/M PEG, and 2.6x EV/Revenue (14.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EPSN (-3.0% ROE) versus GFR (-3.5% ROE) capital efficiency.

In options market volatility and institutional positioning, EPSN carries 51.0% implied volatility (13th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.31β · 43% Vol realized risk). By comparison, GFR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 140% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.